Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1994 May;62(5):1813–1819. doi: 10.1128/iai.62.5.1813-1819.1994

Effect of genetic switching of capsular type on virulence of Streptococcus pneumoniae.

T Kelly 1, J P Dillard 1, J Yother 1
PMCID: PMC186414  PMID: 8168944

Abstract

To assess the role of capsular serotypes in the virulence of Streptococcus pneumoniae, we have constructed isogenic derivatives differing only in the type of capsule expressed. Strains of types 2, 5, and 6B were converted to type 3 by transformation and selection for an erythromycin resistance marker linked to the type 3 capsule locus. Characterization studies revealed that these type 3 derivatives were indistinguishable from the type 2, type 5, and type 6B parental strains in terms of restriction enzyme fragment pattern and expression of pneumococcal surface protein A (PspA). Expression of the type 3 capsule did not alter the mouse virulence of the similarly virulent type 2 strain. However, alteration of capsule type had a profound effect on the virulence of the type 5 and type 6B derivatives. The highly virulent type 5 strain was essentially avirulent when expressing the type 3 capsule. Conversely, the 50% lethal dose of the relatively avirulent type 6B strain was reduced > 100-fold when the type 3 capsule was expressed. Thus, the serotype of capsule expressed has a major effect on virulence, and this effect is dependent upon the genetic background of the recipient strain.

Full text

PDF
1813

Images in this article

1816Image
on p.1816
1816Image
on p.1816
1816Image
on p.1816

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Braconier J. H., Odeberg H. Granulocyte phagocytosis and killing virulent and avirulent serotypes of Streptococcus pneumoniae. J Lab Clin Med. 1982 Aug;100(2):279–287. [PubMed] [Google Scholar]
  2. Briles D. E., Claflin J. L., Schroer K., Forman C. Mouse Igg3 antibodies are highly protective against infection with Streptococcus pneumoniae. Nature. 1981 Nov 5;294(5836):88–90. doi: 10.1038/294088a0. [DOI] [PubMed] [Google Scholar]
  3. Briles D. E., Crain M. J., Gray B. M., Forman C., Yother J. Strong association between capsular type and virulence for mice among human isolates of Streptococcus pneumoniae. Infect Immun. 1992 Jan;60(1):111–116. doi: 10.1128/iai.60.1.111-116.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Briles D. E., Forman C., Crain M. Mouse antibody to phosphocholine can protect mice from infection with mouse-virulent human isolates of Streptococcus pneumoniae. Infect Immun. 1992 May;60(5):1957–1962. doi: 10.1128/iai.60.5.1957-1962.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Briles D. E., Horowitz J., McDaniel L. S., Benjamin W. H., Jr, Claflin J. L., Booker C. L., Scott G., Forman C. Genetic control of the susceptibility to pneumococcal infection. Curr Top Microbiol Immunol. 1986;124:103–120. doi: 10.1007/978-3-642-70986-9_7. [DOI] [PubMed] [Google Scholar]
  6. Briles D. E., Nahm M., Schroer K., Davie J., Baker P., Kearney J., Barletta R. Antiphosphocholine antibodies found in normal mouse serum are protective against intravenous infection with type 3 streptococcus pneumoniae. J Exp Med. 1981 Mar 1;153(3):694–705. doi: 10.1084/jem.153.3.694. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Brown E. J., Hosea S. W., Hammer C. H., Burch C. G., Frank M. M. A quantitative analysis of the interactions of antipneumococcal antibody and complement in experimental pneumococcal bacteremia. J Clin Invest. 1982 Jan;69(1):85–98. doi: 10.1172/JCI110444. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Crain M. J., Waltman W. D., 2nd, Turner J. S., Yother J., Talkington D. F., McDaniel L. S., Gray B. M., Briles D. E. Pneumococcal surface protein A (PspA) is serologically highly variable and is expressed by all clinically important capsular serotypes of Streptococcus pneumoniae. Infect Immun. 1990 Oct;58(10):3293–3299. doi: 10.1128/iai.58.10.3293-3299.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Fine D. P. Pneumococcal type-associated variability in alternate complement pathway activation. Infect Immun. 1975 Oct;12(4):772–778. doi: 10.1128/iai.12.4.772-778.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Finland M., Barnes M. W. Changes in occurrence of capsular serotypes of Streptococcus pneumoniae at Boston City Hospital during selected years between 1935 and 1974. J Clin Microbiol. 1977 Feb;5(2):154–166. doi: 10.1128/jcm.5.2.154-166.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Giebink G. S., Verhoef J., Peterson P. K., Quie P. G. Opsonic requirements for phagocytosis of Streptococcus pneumoniae types VI, XVIII, XXIII, and XXV. Infect Immun. 1977 Nov;18(2):291–297. doi: 10.1128/iai.18.2.291-297.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Gray B. M., Dillon H. C., Jr Clinical and epidemiologic studies of pneumococcal infection in children. Pediatr Infect Dis. 1986 Mar-Apr;5(2):201–207. doi: 10.1097/00006454-198603000-00009. [DOI] [PubMed] [Google Scholar]
  13. Hostetter M. K. Serotypic variations among virulent pneumococci in deposition and degradation of covalently bound C3b: implications for phagocytosis and antibody production. J Infect Dis. 1986 Apr;153(4):682–693. doi: 10.1093/infdis/153.4.682. [DOI] [PubMed] [Google Scholar]
  14. Jansson P. E., Lindberg B., Anderson M., Lindquist U., Henrichsen J. Structural studies of the capsular polysaccharide from Streptococcus pneumoniae type 2, a reinvestigation. Carbohydr Res. 1988 Oct 15;182(1):111–117. doi: 10.1016/0008-6215(88)84095-3. [DOI] [PubMed] [Google Scholar]
  15. Jansson P. E., Lindberg B., Lindquist U. Structural studies of the capsular polysaccharide from Streptococcus pneumoniae type 5. Carbohydr Res. 1985 Jul 1;140(1):101–110. doi: 10.1016/0008-6215(85)85053-9. [DOI] [PubMed] [Google Scholar]
  16. Kenne L., Lindberg B. The structure of the Streptococcus pneumoniae type 29 polysaccharide: a re-examination. Carbohydr Res. 1988 Dec 31;184:288–291. doi: 10.1016/0008-6215(88)80033-8. [DOI] [PubMed] [Google Scholar]
  17. Knecht J. C., Schiffman G., Austrian R. Some biological properties of Pneumococcus type 37 and the chemistry of its capsular polysaccharide. J Exp Med. 1970 Sep 1;132(3):475–487. doi: 10.1084/jem.132.3.475. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Matthay K. K., Mentzer W. C., Wara D. W., Preisler H. K., Lameris N. B., Ammann A. J. Evaluation of the opsonic requirements for phagocytosis of Streptococcus pneumoniae serotypes VII, XIV, and XIX by chemiluminescence assay. Infect Immun. 1981 Jan;31(1):228–235. doi: 10.1128/iai.31.1.228-235.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. McDaniel L. S., Scott G., Kearney J. F., Briles D. E. Monoclonal antibodies against protease-sensitive pneumococcal antigens can protect mice from fatal infection with Streptococcus pneumoniae. J Exp Med. 1984 Aug 1;160(2):386–397. doi: 10.1084/jem.160.2.386. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. McDaniel L. S., Scott G., Widenhofer K., Carroll J. M., Briles D. E. Analysis of a surface protein of Streptococcus pneumoniae recognised by protective monoclonal antibodies. Microb Pathog. 1986 Dec;1(6):519–531. doi: 10.1016/0882-4010(86)90038-0. [DOI] [PubMed] [Google Scholar]
  21. McDaniel L. S., Sheffield J. S., Delucchi P., Briles D. E. PspA, a surface protein of Streptococcus pneumoniae, is capable of eliciting protection against pneumococci of more than one capsular type. Infect Immun. 1991 Jan;59(1):222–228. doi: 10.1128/iai.59.1.222-228.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. McDaniel L. S., Sheffield J. S., Swiatlo E., Yother J., Crain M. J., Briles D. E. Molecular localization of variable and conserved regions of pspA and identification of additional pspA homologous sequences in Streptococcus pneumoniae. Microb Pathog. 1992 Oct;13(4):261–269. doi: 10.1016/0882-4010(92)90036-n. [DOI] [PubMed] [Google Scholar]
  23. Stephens C. G., Williams R. C., Jr, Reed W. P. Classical and alternative complement pathway activation by pneumococci. Infect Immun. 1977 Aug;17(2):296–302. doi: 10.1128/iai.17.2.296-302.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Szu S. C., Clarke S., Robbins J. B. Protection against pneumococcal infection in mice conferred by phosphocholine-binding antibodies: specificity of the phosphocholine binding and relation to several types. Infect Immun. 1983 Feb;39(2):993–999. doi: 10.1128/iai.39.2.993-999.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Viering T. P., Fine D. P. Genetic analysis of Streptococcus pneumoniae serotypes with the use of DNA fingerprinting. J Infect Dis. 1989 Jul;160(1):76–82. doi: 10.1093/infdis/160.1.76. [DOI] [PubMed] [Google Scholar]
  26. Waltman W. D., McDaniel L. S., Gray B. M., Briles D. E. Variation in the molecular weight of PspA (pneumococcal surface protein A) among Streptococcus pneumoniae. Microb Pathog. 1990 Jan;8(1):61–69. doi: 10.1016/0882-4010(90)90008-e. [DOI] [PubMed] [Google Scholar]
  27. Winkelstein J. A., Abramovitz A. S., Tomasz A. Activation of C3 via the alternative complement pathway results in fixation of C3b to the pneumococcal cell wall. J Immunol. 1980 May;124(5):2502–2506. [PubMed] [Google Scholar]
  28. Yother J., Forman C., Gray B. M., Briles D. E. Protection of mice from infection with Streptococcus pneumoniae by anti-phosphocholine antibody. Infect Immun. 1982 Apr;36(1):184–188. doi: 10.1128/iai.36.1.184-188.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Yother J., Handsome G. L., Briles D. E. Truncated forms of PspA that are secreted from Streptococcus pneumoniae and their use in functional studies and cloning of the pspA gene. J Bacteriol. 1992 Jan;174(2):610–618. doi: 10.1128/jb.174.2.610-618.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Yother J., McDaniel L. S., Briles D. E. Transformation of encapsulated Streptococcus pneumoniae. J Bacteriol. 1986 Dec;168(3):1463–1465. doi: 10.1128/jb.168.3.1463-1465.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. van de Rijn I., Kessler R. E. Growth characteristics of group A streptococci in a new chemically defined medium. Infect Immun. 1980 Feb;27(2):444–448. doi: 10.1128/iai.27.2.444-448.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES